These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23024263)

  • 1. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms.
    Araújo TG; Oliveira AG; Carvalho BM; Guadagnini D; Protzek AO; Carvalheira JB; Boschero AC; Saad MJ
    Endocrinology; 2012 Dec; 153(12):5760-9. PubMed ID: 23024263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice.
    Sakamaki Y; Matsumoto K; Mizuno S; Miyoshi S; Matsuda H; Nakamura T
    Am J Respir Cell Mol Biol; 2002 May; 26(5):525-33. PubMed ID: 11970903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes.
    Mellado-Gil J; Rosa TC; Demirci C; Gonzalez-Pertusa JA; Velazquez-Garcia S; Ernst S; Valle S; Vasavada RC; Stewart AF; Alonso LC; Garcia-Ocaña A
    Diabetes; 2011 Feb; 60(2):525-36. PubMed ID: 20980460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration.
    Alvarez-Perez JC; Ernst S; Demirci C; Casinelli GP; Mellado-Gil JM; Rausell-Palamos F; Vasavada RC; Garcia-Ocaña A
    Diabetes; 2014 Jan; 63(1):216-23. PubMed ID: 24089510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of HGF/c-Met signaling in pancreatic β-cells leads to incomplete maternal β-cell adaptation and gestational diabetes mellitus.
    Demirci C; Ernst S; Alvarez-Perez JC; Rosa T; Valle S; Shridhar V; Casinelli GP; Alonso LC; Vasavada RC; García-Ocana A
    Diabetes; 2012 May; 61(5):1143-52. PubMed ID: 22427375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic beta-cells.
    Izumida Y; Aoki T; Yasuda D; Koizumi T; Suganuma C; Saito K; Murai N; Shimizu Y; Hayashi K; Odaira M; Kusano T; Kushima M; Kudano M
    Biochem Biophys Res Commun; 2005 Jul; 333(1):273-82. PubMed ID: 15950193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
    Corpechot C; Barbu V; Wendum D; Chignard N; Housset C; Poupon R; Rosmorduc O
    Am J Pathol; 2002 Feb; 160(2):613-20. PubMed ID: 11839582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient reciprocal change of renal hepatocyte growth factor and transforming growth factor-beta1 may relate to renal hypertrophy in rats with liver injury or unilateral nephrectomy.
    Tsau YK; Tsai IJ; Chen YM
    Pediatr Res; 2006 Apr; 59(4 Pt 1):494-9. PubMed ID: 16549518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREB is a regulatory target for the protein kinase Akt/PKB in the differentiation of pancreatic ductal cells into islet β-cells mediated by hepatocyte growth factor.
    Li XY; Zhan XR; Liu XM; Wang XC
    Biochem Biophys Res Commun; 2011 Jan; 404(2):711-6. PubMed ID: 21156158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
    Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance.
    Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
    Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats.
    Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R
    Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
    Kim WH; Matsumoto K; Bessho K; Nakamura T
    Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
    Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
    J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
    Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
    Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.
    Muratsu J; Iwabayashi M; Sanada F; Taniyama Y; Otsu R; Rakugi H; Morishita R
    Sci Rep; 2017 Mar; 7(1):130. PubMed ID: 28273932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.